26. HTLV-1-associated myelopathy Clinical trials / Disease details
Clinical trials : 28 / Drugs : 48 - (DrugBank : 28) / Drug target genes : 38 - Drug target pathways : 127
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01640002 (ClinicalTrials.gov) | May 2012 | 11/7/2012 | A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder | A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder | Overactive Bladder Associated With HTLV-1 | Drug: Propantheline Bromide;Drug: Placebo | Hospital Universitário Professor Edgard Santos | NULL | Recruiting | 18 Years | N/A | Both | 42 | Phase 1 | Brazil |